Abstract:BACKGROUND RNA interference using short hairpin RNA (shRNA) can mediate sequence-specific inhibition of gene expression in mammalian cells. A vector-based approach for synthesizing shRNA has been developed recently. Overexpression of P-glycoprotein (P-gp), the MDR1 gene product, confers multidrug resistance (MDR) to cancer cells. In this study, we reversed MDR using shRNA expression vectors in a multidrug-resistant human breast cancer cell line (MCF-7/AdrR). METHODS The two shRNA expression vectors were constructed and introduced into MCF-7/AdrR cells. Expression of MDR1 mRNA was assessed by RT-PCR, and P-gp expression was determined by Western Blot and immunocytochemistry. Apoptosis and sensitization of the breast cancer cells to doxorubicin were quantified by flow cytometry and methyl thiazolyl tetrazolium (MTT) assays, respectively. Cellular daunorubicin accumulation was assayed by laser confocal scanning microscopy (LCSM). Statistical significance of differences in mean values was evaluated by Student's t tests. P < 0.05 was considered statistically significant. RESULTS In MCF-7/AdrA cells transfected with MDR1-A and MDR1-B shRNA expression vectors, RT-PCR showed that MDR1 mRNA expression was reduced by 40.9% (P < 0.05), 30.1% (P < 0.01) (transient transfection) and 37.6% (P < 0.05), 28.0% (P < 0.01) (stable transfection), respectively. Western Blot and immunocytochemistry showed that P-gp expression was significantly and specifically inhibited. Resistance against doxorubicin was decreased from 162-fold to 109-fold (P < 0.05), 54-fold (P < 0.01) (transient transfection) and to 108-fold (P < 0.05), 50-fold (P < 0.01) (stable transfection). Furthermore, shRNA vectors significantly enhanced the cellular daunorubicin accumulation. The combination of shRNA vectors and doxorubicin significantly induced apoptosis in MCF-7/AdrR cells. CONCLUSIONS shRNA expression vectors effectively reduce MDR expression in a sustained fashion and can restore the sensitivity of drug-resistant cancer cells to conventional chemotherapeutic agents.

Effect of mismatched shRNA on reversing the multidrug resistance of leukemia cell

[Study on RNA Interference Reversing the Multidrug Resistance of Leukemia Cell].

Mdr-1 ribozyme in the reversal of multidrug resistance in human ovarian cancer]

[Reversal of Mdrl Gene-Dependent Multidrug Resistance in Multidrug Resistance Human Leukemia Cell Line K562/ADM Using Short Hairpin RNA Expression Vectors].

[Reversal of leukemia multidrug resistance by sequence-specific short hairpin RNA]

Reversal of Multidrug Resistance by MDR1 Shrna Expression Vector in Human Leukemia K562/A02cells

Reversal of Multidrug Resistance by Magnetic Fe3o4 Nanoparticle Copolymerizating Daunorubicin and Mdr1 Shrna Expression Vector in Leukemia Cells

Study On Rna Interference Reversing Multidrug Resistance In K562/A02 Resistant Leukemia Cell.

Drug Resistance Reversal of Doxorubicin-resistant Human Leukemia Cell Line K562/ADM Through Down-regulating MDR1 Gene

[Reversal of Multidrug Resistance of K562/A02 Cell Line by Mdr1 and GSTpi Gene Silence].

Mechanism underlying drug resistance of HepG2/ADM cells silently reversed by lentivirus-mediated BC047440 gene during chemotherapy

Reversal of Multi-Drug Resistance in Human Breast Cancer MCF-7/ADR Cells by Short Hairpin RNA Expression Plasmids

[Reversal of Multi-Drug Resistance in K562/A02 Cells by Two Short Hairpin RNAs (shrna) of Mdr1].

[Functional Study of Mdr1 and GSTpi Expression Reversed by Hairpin Sirna in K562/A02 Cell Line].

Reversal of multi-drug resistance in K562/A02 cells by two short hairpin RNAs(shRNA) of mdr1 and mcll genes

Reversal of MDR1 Gene-Dependent Multidrug Resistance Using Short Hairpin RNA Expression Vectors

Short Hairpin RNA Expression Reversing MDR1 Gene-Dependent Multidrug Resistance of Human Breast Cancer Cell Line (Mcf-7/Adrr)

Reversal of Multidrug Resistance in Leukemia Cells by Small Interfering RNAs Combined with Antisense Oligodeoxyribonucleotides for Inhibition of MDR1 Gene Expression

Reversal of Drug-Resistance of Leukemia K562/ADM Cells to Chemotherapeutical Agents by Small Interfering RNA

[Reversal of Multi-Drug Resistance in K562/A02 Cells by Small Interference RNA of Mdr1 Gene].

Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.